A Double-Blind, Placebo-Controlled Trial of Lofexidine for Opioid Withdrawal Syndrome

被引：0
|
作者：
Ryan, S.
Pirner, M.
Clinch, T.
Fishman, M.
机构：
[1] BrightView LLC, Cincinnati, OH USA
[2] US WorldMeds LLC, Louisville, KY USA
[3] Johns Hopkins Sch Med, Baltimore, MD USA
[4] Maryland Treatment Ctr, Baltimore, MD USA
来源：
ANNALS OF EMERGENCY MEDICINE | 2018年 / 72卷 / 04期
关键词：
D O I：
10.1016/j.annemergmed.2018.08.013
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
8
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: Lofexidine is not a useful adjunct to chlordiazepoxide
    Keaney, F
    Strang, J
    Gossop, M
    Marshall, EJ
    Farrell, M
    Welch, S
    Hahn, B
    Gonzalez, A
    ALCOHOL AND ALCOHOLISM, 2001, 36 (05): : 426 - 430
  • [2] A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
    Yu, Elmer
    Miotto, Karen
    Akerele, Evaristo
    Montgomery, Ann
    Elkashef, Ahmed
    Walsh, Robert
    Montoya, Ivan
    Fischman, Marian W.
    Collins, Joseph
    McSherry, Frances
    Boardman, Kathy
    Davies, David K.
    O'Brien, Charles P.
    Ling, Walter
    Kleber, Herbert
    Herman, Barbara H.
    DRUG AND ALCOHOL DEPENDENCE, 2008, 97 (1-2) : 158 - 168
  • [3] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MAGNESIUM-SULFATE IN THE ETHANOL WITHDRAWAL SYNDROME
    WILSON, A
    VULCANO, B
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1984, 8 (06) : 542 - 545
  • [4] Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
    Levin, Frances R.
    Mariani, John J.
    Pavlicova, Martina
    Brooks, Daniel
    Glass, Andrew
    Mahony, Amy
    Nunes, Edward V.
    Bisaga, Adam
    Dakwar, Elias
    Carpenter, Kenneth M.
    Sullivan, Maria A.
    Choi, Jean C.
    DRUG AND ALCOHOL DEPENDENCE, 2016, 159 : 53 - 60
  • [5] DOUBLE-BLIND PLACEBO-CONTROLLED PILOT TRIAL OF MODAFINIL FOR METHAMPHETAMINE WITHDRAWAL
    Lee, Nicole
    Pennay, Amy
    Hester, Rob
    Ferris, Jason
    Dunlop, Adrian
    DRUG AND ALCOHOL REVIEW, 2009, 28 : A75 - A75
  • [6] Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore
    Guo, Song
    Manning, Victoria
    Yang, Yi
    Koh, Puay Kee
    Chan, Edwin
    de Souza, Nurun Nisa
    Assam, Pryseley Nkouibert
    Sultana, Rehena
    Wijesinghe, Ruki
    Pangjaya, Julius
    Kandasami, Gomathinayagam
    Cheok, Christopher
    Lee, Kae Meng
    Wong, Kim Eng
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 91 : 1 - 11
  • [7] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MAGNESIUM-SULFATE IN THE ETHANOL WITHDRAWAL SYNDROME - RESPONSE
    WILSON, A
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1985, 9 (04) : 384 - 385
  • [8] OPIPRAMOL IN THE CLIMACTERIC SYNDROME - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    VANLITH, ND
    MOTKE, JCT
    MATURITAS, 1983, 5 (01) : 17 - 23
  • [9] A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EXAMINING SEX DIFFERENCES AND THE IMPACT OF LOFEXIDINE ON STRESS AND OPIOID CRAVING IN ADULTS WITH OPIOID USE DISORDERS
    Guille, Constance
    Baker, Nathaniel
    Neelon, Brian
    Tomko, Rachel
    Nunn, Lisa
    McRae-Clark, Aimee
    Brady, Kathleen
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 284 - 285
  • [10] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
12345